NADAC acquisition cost data for CLOCORTOLONE PIVALATE 0.1% CRM. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 51672416606 | $3.97 | 2022-11-23 | Rx |
| 66993094748 | $3.97 | 2022-11-23 | Rx |
| 51672416606 | $3.97 | 2022-11-23 | Rx |
| 66993094748 | $3.97 | 2022-11-23 | Rx |
| 51672416606 | $3.97 | 2022-11-23 | Rx |
| 66993094748 | $3.97 | 2022-11-23 | Rx |
| 51672416606 | $3.97 | 2022-11-23 | Rx |
| 66993094748 | $3.97 | 2022-11-23 | Rx |
| 51672416606 | $3.97 | 2022-11-23 | Rx |
| 66993094748 | $3.97 | 2022-11-23 | Rx |
Generic: Clocortolone Pivalate | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $38.4K | 151 | 1,018 | $5.28 |
| 2020 | $404.0K | 1,294 | 1,043 | $5.32 |
| 2021 | $430.8K | 1,342 | 946 | $5.26 |
| 2022 | $291.3K | 981 | 750 | $5.23 |
| 2023 | $243.6K | 811 | 577 | $5.11 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| New Jersey | $31.5K | 99 | 63 |
| Pennsylvania | $29.6K | 100 | 73 |
| Texas | $23.3K | 48 | 39 |
| California | $22.7K | 86 | 60 |
| New York | $17.3K | 47 | 36 |
| Florida | $16.2K | 54 | 39 |
| Georgia | $13.2K | 48 | 40 |
| Colorado | $7.7K | 25 | 14 |
| Maryland | $7.6K | 24 | 18 |
| Alabama | $7.2K | 27 | 17 |
| North Carolina | $6.3K | 26 | 18 |
| Michigan | $6.1K | 22 | 15 |
| Tennessee | $4.8K | 18 | 11 |
| Illinois | $3.8K | 14 | 12 |
| Arizona | $3.6K | 13 | N/A |
| Virginia | $3.6K | 14 | N/A |
| Ohio | $3.4K | 15 | 14 |
| Missouri | $3.4K | 13 | N/A |
| Louisiana | $3.1K | 12 | N/A |
| Connecticut | $3.1K | 11 | N/A |
| South Carolina | $2.9K | 11 | N/A |
| Wisconsin | $2.7K | 12 | N/A |
| Kentucky | $2.5K | 11 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.